bpc 157 safety human study The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and BPC-157: Experimental Peptide Creates Risk
Description
The reticulocyte count (immature red blood cells) typically rises within 35 days of starting treatment, indicating that bone marrow is responding appropriately to therapy
doi: 10.1016/j.engmic.2024.100167
In such cases, intramuscular injections may be a better choice
Maintenance Dosing Guidelines After the initial treatment, patients need maintenance dosing to keep vitamin B12 levels up
